Protease-activated receptors: sentries for inflammation?

By Cocks T.M.T.M.   Moffatt J.D.J.D.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 3, 2000-03 ,pp. : 103-108

Elsevier

Access to resources Recommend Favorite

Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?

By  

Current Drug Targets, Vol. 7, Iss. 5, 2006-05 ,pp. : 629-637

Bentham Science Publishers

Access to resources Recommend Favorite

Protease-Activated Receptors as Therapeutic Targets in Visceral Pain

By  

Current Neuropharmacology, Vol. 11, Iss. 6, 2013-12 ,pp. : 598-605

Bentham Science Publishers

Access to resources Recommend Favorite

Vorapaxar: a novel protease-activated receptor-1 inhibitor

By Gurbel Paul A   Jeong Young-Hoon   Tantry Udaya S  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1445-1453

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite